Nivolumab Improves Survival in Relapsed Mesothelioma ...Middle East

Medscape - News
In the first placebo-controlled phase 3 trial in relapsed mesothelioma, immunotherapy with nivolumab showed a significant improvement in survival. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Nivolumab Improves Survival in Relapsed Mesothelioma )

Apple Storegoogle play

Also on site :

Most viewed in News